InvestorsHub Logo
Followers 54
Posts 3476
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 1670

Monday, 07/31/2017 3:16:31 PM

Monday, July 31, 2017 3:16:31 PM

Post# of 3283

combo trial of poziotinib w T-DM1 mentioned during the Q1 2017 CC

This would be in 2nd line breast cancer. Nothing on clinical trials yet. Wonder who else will be sponsoring it? Genentech? NIH? Individual sponsor (such as MD Anderson)? Hope they don't go stealth on us regarding some more info on it at the quarterly.